A new study suggests COPD patients experience improved lung function and breathlessness after direct switch from long-acting bronchodilators or steroid containing combination therapies to ...

Purpose: The pharmacology, pharmaceutics, clinical efficacy, adverse effects, cost, and dosage and administration of long-acting risperidone injection are reviewed. Summary: Risperidone is the ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

Background Whether inhaled corticosteroids (ICSs) reduce major adverse cardiovascular events (MACEs) in people with chronic obstructive pulmonary disease (COPD) is debated. Objectives To establish, ...

When patients cannot adhere to inhaler instructions — whether because of cognitive or physical limitations — a nebulized LAMA might offer another method to safely deliver medication. To that end, GOLD ...

which has just declined to approve the company's long-acting formulation of schizophrenia drug risperidone. The US regulator issued a complete response letter (CRL) for the MedinCell-partnered ...

Asthma is a disease of the lungs that affects people of all ages and both sexes. About 1 in 13 people in the United States ...

Exacerbation rates were similar among most patients with COPD who used triple therapy vs dual bronchodilators after previously using LABA/ICS therapy. Patients who switched to triple therapy for ...

Seventy-two percent of all participants were prescribed a combination of inhaled corticosteroid and long-acting bronchodilator therapy; 25% took a long-acting bronchodilator without inhaled ...

long-acting bronchodilator named formoterol (e.g. Symbicort a combination of budesonide and formoterol) are also being prescribed as daily controller medications and for treatment of asthma flares.

Approximately $36 million and $42 million net product sales of Ohtuvayre for the fourth quarter and full year 2024, ...